NovoCure Limited (Nasdaq: NVCR) has a market capitalization of $1.74B. Last close $15.71 (as of 2026-10-21); 52-week range $9.82 to $21.45. ORTEX data as of 2026-10-19: short interest is 11.77% of free float, 7.7 days to cover and the average cost to borrow is 0.48%.